Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Norbert G. Riedel
Chairman
Eton Pharmaceuticals, Inc. (ETON)Equibles does not estimate personal net worth.
Get an email with a short summary when Eton Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ETON alertsAbout Norbert G. Riedel
Norbert G. Riedel is recorded as Chairman at Eton Pharmaceuticals, Inc. (ETON). The newest filing on record that lists Norbert G. Riedel as Chairman at Eton Pharmaceuticals, Inc. (ETON) is dated April 24, 2026. Eton Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Eton Pharmaceuticals, Inc. includes Sean Brynjelsen (CEO and Board Member), James Gruber (CFO), Judith Matthews (CFO) and 4 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at Eton Pharmaceuticals, Inc.
- Sean Brynjelsen CEO, Board Member
- James Gruber CFO
- Judith Matthews CFO
- Danka Radosavljevic COO
- Charles J. Casamento Board Member
- Jenn Adams Board Member
- Paul V. Maier Board Member
Recent activity
No call appearances or filed executive changes recorded yet.